IKTInhibikase Therapeutics, Inc.
2.390USD-2.45%Mkt Cap: 333.49M $P/E: —3d ago
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH)…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap333.49M $
Enterprise Value268.86M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-48.26M $
Revenue/Share—
Last Price2.390 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees35
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45719W1062
Valuation
P/E (Trailing)—
P/E (Forward)-5.43
PEG—
EV/EBITDA-4.06
EV/Revenue—
P/S—
P/B2.68
EPS (TTM)-0.42
EPS (Forward)-0.43
52W Range
1.33088% of range2.530
52W High2.530 USD
52W Low1.330 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-27.91%
ROA-26.63%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.79M $
CapEx (TTM)452.02K $
FCF Margin—
FCF Yield-6.63%
Net Debt-159.02M $
Net Debt/EBITDA2.40
Balance Sheet
Debt/Equity0.00
Current Ratio15.82
Quick Ratio15.50
Book Value/Sh0.8780 USD
Cash/Share0.8730 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJun 30, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+151.0%
Target Range3.000 USD – 8.000 USD
$3.000+151.0% to mean$8.000
# Analysts9
Ownership
Shares Out.139.54M
Float107.13M
Insiders6.09%
Institutions92.22%
Short Interest
Short Ratio18.8d
Short % Float17.87%
Short % Out.12.19%
Shares Short19.14M
Short (prev mo.)19.42M
Technical
SMA 502.115 (+13.0%)
SMA 2001.827 (+30.8%)
Beta0.95
S&P 52W Chg18.16%
Avg Vol (30d)813.12K
Avg Vol (10d)435.04K
Technical Indicators
RSI (14)57.9
MACD0.0903
MACD Signal0.1039
MACD Hist.-0.0136
BB Upper2.539 USD
BB Middle2.364 USD
BB Lower2.189 USD
BB Width14.79%
ATR (14)0.1215 USD
Vol Ratio (20d)0.46x